Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth Disease
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: The study aim was to evaluate the impact of body mass index (BMI) on disease progression over 2-years in children with Charcot-Marie-Tooth disease (CMT). Methods: BMI was classified in 242 participants 3-20 years with CMT enrolled in the Inherited Neuropathy Consortium, using the International Obesity Task Force (based on adult BMI values, kg/m2). Groups were categorised as severely underweight (BMI<17kg/m2), underweight (BMI≥17kg/m2 to <18.5kg/m2), healthy weight (BMI≥18.5kg/m2 to <25kg/m2), overweight (BMI≥25 kg/m2 to <30 kg/m2) and obese (BMI≥30kg/m2). Disease severity was assessed using the CMT Pediatric Scale (CMTPedS), a clinical outcome assessment of disability (0-44 points, mild-severe).
Results: At baseline, compared to being healthy weight (mean CMTPedS 15.48, SD 9.22), children who were severely underweight (mean CMTPedS difference 9.03, 95%CI 0.94-17.12; p=0.02,), underweight (mean CMTPedS difference 5.97, 95%CI 0.62-11.31; p=0.02), or obese (mean CMTPedS difference 7.96, 95%CI 1.03-14.88; p=0.015) exhibited greater disability. At 2-years, compared to being healthy weight (mean CMTPedS 17.53, SD 9.41), children who were severely underweight exhibited greater disability (mean CMTPedS difference 9.27, 95%CI 0.90-17.64; p=0.02). Over the 2-year periods, mean CMTPedS for the whole sample deteriorated by 1.72 points (95%CI 1.09-2.38; p<0.001), with severely underweight children progressing at the fastest rate (mean CMTPedS change of 2.3, 95%CI 1.53 – 6.13; p=0.21). In children who did not change BMI categories over 2-years (69% of sample), CMTPedS scores deteriorated faster in those who were severely underweight (mean CMTPedS change 6.40 points 95%CI 2.42 -10.38; p=0.01) than those of a healthy weight (mean CMTPedS change 1.79 points 95%CI 0.93 - 2.69; p<0.001). For children who changed BMI categories (31% of sample), CMTPedS scores deteriorated faster in children who became overweight/obese (mean CMTPedS change 2.76 points 95%CI 0.11 - 5.41; p=0.031).
Conclusion: Children with CMT who severely underweight, underweight, or obese exhibited greater disability at baseline. Over the 2-year period in those whose BMI remained stable, severely underweight children deteriorated at the fastest rate. For children who changed BMI categories over the 2 years, CMTPedS scores deteriorated faster in children who became overweight/obese. Interventions that maintain or improve BMI towards a healthy weight may reduce disability in children with CMT.
- Received September 14, 2022.
- Accepted in final form April 20, 2023.
- © 2023 American Academy of Neurology Unauthorized reproduction of this article is prohibited
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
- No related articles found.